Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sruthi Ravindranathan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|May 29, 2024
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic CancerTenzin Passang, Shuhua Wang, Hanwen Zhang, et al.
Theranostics|August 1, 2022
Raman spectroscopy reveals phenotype switches in breast cancer metastasisSantosh Kumar Paidi, Joel Rodriguez Troncoso, Mason G Harper, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2024
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cellsNarendiran Rajasekaran, Xiaoguang Wang, Sruthi Ravindranathan, et al.
Biomedical Optics Express|February 29, 2024
Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopyJoel Rodriguez Troncoso, Umme Marium Mim, Jesse D Ivers, et al.
Blood|April 20, 2022
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expressionJingru Zhu, Yitong Wang, Jingxia Li, et al.
Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.
Nature Communications|October 27, 2022
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinomaSruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|May 29, 2024
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic CancerTenzin Passang, Shuhua Wang, Hanwen Zhang, et al.
Theranostics|August 1, 2022
Raman spectroscopy reveals phenotype switches in breast cancer metastasisSantosh Kumar Paidi, Joel Rodriguez Troncoso, Mason G Harper, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2024
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cellsNarendiran Rajasekaran, Xiaoguang Wang, Sruthi Ravindranathan, et al.
Biomedical Optics Express|February 29, 2024
Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopyJoel Rodriguez Troncoso, Umme Marium Mim, Jesse D Ivers, et al.
Blood|April 20, 2022
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expressionJingru Zhu, Yitong Wang, Jingxia Li, et al.
Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.
Nature Communications|October 27, 2022
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinomaSruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, et al.
Pageof 2